Form 4 for MRNA Moderna
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001127602-25-004913 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-12 | MRNA | Klinger Shannon Thyme | CLO | A - Grant | $0.00 | +2,047 | 22.5K | +10% | $0 | |
| 2025-02-14 | 2025-02-12 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $30.93 | -1,068 | 21.4K | -5% | -$33.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | A | A | 2,047 | $0.00 | 22,493 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-12 | F | D | 1,068 | $30.93 | 21,425 | D | — | — |